Cargando…
Relative Adipose Tissue Failure in Alström Syndrome Drives Obesity-Induced Insulin Resistance
Obesity is a major risk factor for insulin resistance (IR) and its attendant complications. The pathogenic mechanisms linking them remain poorly understood, partly due to a lack of intermediary monogenic human phenotypes. Here, we report on a monogenic form of IR-prone obesity, Alström syndrome (ALM...
Autores principales: | Geberhiwot, Tarekegn, Baig, Shanat, Obringer, Cathy, Girard, Dorothée, Dawson, Charlotte, Manolopoulos, Konstantinos, Messaddeq, Nadia, Bel Lassen, Pierre, Clement, Karine, Tomlinson, Jeremy W., Steeds, Richard P., Dollfus, Hélène, Petrovsky, Nikolai, Marion, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881858/ https://www.ncbi.nlm.nih.gov/pubmed/32994277 http://dx.doi.org/10.2337/db20-0647 |
Ejemplares similares
-
Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial
por: Baig, Shanat, et al.
Publicado: (2018) -
Prospective cardiovascular magnetic resonance imaging in adults with Alström syndrome: silent progression of diffuse interstitial fibrosis
por: Baig, Shanat, et al.
Publicado: (2020) -
Consensus clinical management guidelines for Alström syndrome
por: Tahani, Natascia, et al.
Publicado: (2020) -
Alström syndrome: a paradigm for diffuse fibrosis and clinical progression
por: Edwards, Nicola C, et al.
Publicado: (2013) -
Diffuse left ventricular interstitial fibrosis is associated with sub-clinical myocardial dysfunction in Alström Syndrome: an observational study
por: Edwards, Nicola C., et al.
Publicado: (2015)